Medicare
At Medicus, we believe in the power of translating data into evidence. With access to data on 100% of Medicare beneficiaries in traditional (Fee-For-Service) Medicare and Medicare Advantage, Medicus is uniquely positioned to deliver insights that form the foundation of value stories.
To learn more about our Medicare data offering, explore below.
What & Why
Medicare is the primary insurance provider for older adults in the US
63.9 million Americans were enrolled in Medicare, of whom 50% were between age 65 and 74 years, 27% were between age 75 and 84 years, and 10% were age 85 or older
50%
27%
10%
76% of Medicare beneficiaries also
had Part D (drug) coverage
76%
18% were also enrolled in Medicaid
18%
As the US population ages, Medicare data are increasingly important to provide insights on health economics and outcomes associated with healthcare delivery.
As new health policies are enacted (such as the IRA), Medicare data are increasingly important to provide insights on health economics and outcomes associated with such policies.
For more information on the Medicare program, please visit Medicare Beneficiaries at a Glance
Advantages of Medicus
Extensive experience analyzing the Medicare data and communicating results
Methodological rigor and expertise
100% Medicare data
Existing DUA
Regular data refreshes
Track record of publishing Medicare data
Access to Medicare Data
Medicus has access to data on 100% of Medicare beneficiaries in traditional Medicare and Medicare Advantage.
2005
Starting from 2005, Medicus has data in the following areas:
2006
Starting from 2006, Medicus has data on the Part D outpatient prescription drug program.
2015
Starting from 2015, Medicus has data on the Medicare Advantage encounter records.
The Data
Unique identifier for each beneficiary that is consistent over time and across geography
Patient demographics, including age, sex, and race and ethnicity
(allowing for meaningful insights into health disparities)
Paid amounts for medical and pharmacy claims
Population with long-term, stable enrollment
Patient geography down to the 5-digit ZIP Code level (allowing for meaningful insights into geography-related social determinants of health)
(allowing for meaningful insights into geography-related social determinants of health)
Information on prescription drug plan formulary benefits
Date of death from the Social Security Administration
Linkable data on health care providers via their NPI
Linkable data on hospitals via their Medicare provider number and NPI
Drug utilization and treatment patterns
Healthcare resource utilization and costs
Patient journeys
Comparative effectiveness
Consequences of formulary restrictions
Disparities research
Provider profiling
Examples using Medicare Data
Select research manuscripts from Medicus researchers using Medicare data:
Campbell NL, Hines L, Epstein AJ, Walker D, Lockefeer A, Shiozawa A. A 12-year retrospective study of the prevalence of anticholinergic polypharmacy and associated outcomes among Medicare patients with overactive bladder in the USA. Drugs Aging 2021;38(12):1075-1085. doi: 10.1007/s40266-021-00901-2
Nili M, Epstein AJ, Nunag D, Olson A, Borah B. Using group based trajectory modeling for assessing medication adherence to nintedanib among idiopathic pulmonary fibrosis patients. BMC Pulm Med 2023;23(1):230. doi: 10.1186/s12890-023-02496-3
Freedland SJ, Davis MR, Epstein AJ, Arondekar B, Ivanova JI. Healthcare costs in men with metastatic castration-resistant prostate cancer: an analysis of US Medicare fee-for-service claims. Adv Ther 2023;40(10):4480-4492. doi: 10.1007/s12325-023-02572-4
Pimple P, Nunag D, Epstein AJ, Olson AL. Socioeconomic and Clinical Predictors of Antifibrotic Medication Initiation in Medicare Patients with Idiopathic Pulmonary Fibrosis. AMCP Nexus Conference, 2023.
Sawant R, Epstein AJ, Nunag D, Koenig A, Petrillo J. Treatment Patterns and Healthcare Spending among Medicare Beneficiaries with Huntington’s Disease. ISPOR, 2023.
Wallick C, Nunag D, Zuk E, Davis M, Majda T. Long-term Trends in Healthcare Resource Use for US Medicare Patients Following Alzheimer's Disease Diagnosis. AMCP, 2023. Gerbasi ME, Pahwa R,Nunag D, Nejati M, Epstein AJ. Healthcare Research Utilization and Direct Healthcare Spending among Medicare Patients with Essential Tremor. AMCP Nexus Conference, 2023.
Nili M, Epstein AJ, Nunag D, Olson A, Borah B. Association Between Nintedanib Adherence Trajectories and Healthcare Use Among Idiopathic Pulmonary Fibrosis Patients. American Thoracic Society International Conference, 2023.
Epstein AJ, Nili M, Nunag D, Olson A, Borah B. Real-world Medication Adherence Trajectories of Nintedanib among Idiopathic Pulmonary Fibrosis Patients. AMCP Nexus Conference, 2022.
Freedland SJ, Davis M, Epstein AJ, Arondekar B, Ivanova JI. Healthcare Costs among Men with Metastatic Castration-resistant Prostate Cancer (mCRPC) in the US Medicare Population. American Society of Clinical Oncology Quality Care Symposium Annual Meeting, 2022.
Freedland SJ, Davis M, Epstein AJ, Arondekar B, Ivanova JI. Overall Survival by Race and Ethnicity among Men with Metastatic Castration-resistant Prostate Cancer (mCRPC) in the US Medicare Population. American Society of Clinical Oncology Quality Care Symposium Annual Meeting, 2022.
Freedland SJ, Davis M, Epstein AJ, Arondekar B, Ivanova JI. Real-world Treatment Patterns among Men with Metastatic Castration-resistant Prostate Cancer (mCRPC) in the US Medicare Population. American Society of Clinical Oncology Quality Care Symposium Annual Meeting, 2022.
Campbell NL, Shiozawa A, Epstein AJ, Walker D, Lockefeer A, Hines L. A Retrospective Study of the Prevalence of Anticholinergic Poly-pharmacy Use and its Associated Outcomes among Medicare Patients with Overactive Bladder. American Geriatric Society Virtual Annual Scientific Meeting, 2021.
Contact Us
Please email us at contact@medicuseconomics.com to learn more about working with Medicus. We are excited to connect!